Data Sheet - Medsafe
phenergan-gluv3-dsv5-30jan15 Page 3 Use in Pregnancy (Category C) Promethazine, owing to its pharmacological effects, has caused or may be suspected of causing,
Download Data Sheet - Medsafe
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
What!You!Need!to!Know!About!Your!Allergy!Skin!Test ...
www.atlantaallergy.comImportantInformationaboutAllergySkinTesting Patients!scheduled!for!allergy!skin!testing!muststop!taking!any!medications!thatcontain!antihistamines!as!they!will!
COMMON MEDICATIONS SAFE IN PREGNANCY - …
www.cincyobgyn.comCOMMON MEDICATIONS SAFE IN PREGNANCY Clindamycin ACNE: Benzoyl Peroxide Topical Erythromycin . Salicylic Acid. AVOID: Accutane Metamucil. Retin-A . Tetracycline . Minocycline
Safe, Medication, Common, Pregnancy, Common medications safe in pregnancy
240510-Efficacy dementia drugs Drugs avoid …
www.dementiacarestrategies.comMore. . . Copyright © 2008 by Therapeutic Research Center Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249
Drug, Dementia, 240510 efficacy dementia drugs drugs avoid, 240510, Efficacy, Avoid
Drugs To Be Infused Through A Central Line
www.ivs1.comDrugs To Be Infused Through A Central Line (PICC Line) The Infusion Nurses Society Standards of Practice (2006) state that drugs which have a pH less than 5 and
Line, Central, Through, Be infused through a central line, Infused
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.uk25/07/2016 10:44 - VISTAlink folder 2284235 - Page 1/5-1-PACKAGE LEAFLET: INFORMATION FOR THE USER Phenergan 25 mg Tablets promethazine hydrochloride
Information, User, Leaflet, Packages, Package leaflet, Information for the user, Phenergan, Information for the user phenergan
Photosensitizing Medication List - Vitiligo Support
www.vitiligosupport.orgt a n n i n g f a c t b o o k 2 0 0 8 / 2 0 0 9 c h a p t e r t w o 23 looking fit lookingfit.com * Non-steroidal anti-inflammatory drug Reported Photosensitizing Medications
Lists, Medication, Photosensitizing, Photosensitizing medication list